National Cancer Institute - Maryland

Bethesda, Maryland 20892

0 studies enrolling now · 3 studies all time

What they study most

Advanced Pancreatic Ductal Adenocarcinoma (Optional, Dose Expansion, Not Initiated), Advanced Recurrent Malignant Peritoneal Epithelioid Mesothelioma, Advanced Recurrent Malignant Pleural Epithelioid Mesothelioma, Advanced Recurrent Serous Ovarian Cancer, Neoplasms, Solid Tumors

Studies at this site

• A Clinical Study of Anetumab Ravtansine in Adults With Solid Tumors Who Have Been Treated in Previous Bayer-sponsored Anetumab Ravtansine Studies — Stopped early
• First-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express Mesothelin — Completed
• Phase 1b Multi-indication Study of Anetumab Ravtansine in Mesothelin Expressing Advanced Solid Tumors — Completed